Suppr超能文献

头颈部肿瘤患者调强放疗后腮腺功能恢复的研究。

Investigations on parotid gland recovery after IMRT in head and neck tumor patients.

机构信息

Department of Radiotherapy, Medical University Vienna, Vienna, Austria.

出版信息

Strahlenther Onkol. 2010 Dec;186(12):665-71. doi: 10.1007/s00066-010-2157-7. Epub 2010 Nov 30.

Abstract

PURPOSE

in recent years, the role of intensity-modulated radiotherapy (IMRT) for head and neck irradiation has increased. The main motivation is sparing the parotid gland and reduction of xerostomia. Generally, relative parotid volumes have been evaluated for treatment outcome and planning constraints, neglecting that absolute parotid volumes can vary significantly. The aim of the present study was to investigate changes in parotid gland function and set this in relation to absolute volumes.

MATERIAL AND METHODS

46 head and neck patients were treated by sparing at least the contralateral parotid gland. The mean dose to the contralateral gland was limited to 26 Gy. Parotid function was measured with scintigraphy before and at 3, 6, 9, and 12 months after radiotherapy. Gland recovery was correlated with absolute parotid gland volumes and mean dose. Finally the dose-effect relationship was investigated.

RESULTS

the dose-volume histograms (DVHs) for the ipsi- and contralateral glands were significantly different. A correlation between absolute volumes receiving certain doses and the function loss after 3, 6, 9, and 12 months was found. The most significant correlation was found for the absolute volume that received at least 40 Gy (aV40). ED50 values of 23-38 Gy were observed for more than 50% function loss and and 52-68 Gy afor more than 75% function loss.

CONCLUSION

the mean dose, aV40 or aV26, revealed similar correlations with the excretion rate and with recovery. Hence, also absolute volumes can be used for treatment planning. Longer recovery times show higher ED50 values indicating partial regeneration of gland functions.

摘要

目的

近年来,调强放疗(IMRT)在头颈部放疗中的作用日益增加。主要动机是保护腮腺和减少口干。通常,相对腮腺体积已用于评估治疗结果和规划限制,但忽略了绝对腮腺体积可能有很大差异。本研究旨在研究腮腺功能的变化,并将其与绝对体积联系起来。

材料和方法

46 例头颈部患者接受治疗,至少保留对侧腮腺。对侧腺体的平均剂量限制在 26Gy 以内。在放疗前、放疗后 3、6、9 和 12 个月,用闪烁扫描法测量腮腺功能。将腺体恢复与绝对腮腺体积和平均剂量相关联。最后,研究了剂量-效应关系。

结果

同侧和对侧腺体的剂量-体积直方图(DVH)有显著差异。发现绝对体积在一定剂量下与 3、6、9 和 12 个月后的功能丧失之间存在相关性。发现与绝对体积(aV40)的相关性最大,该体积至少接受了 40Gy 的剂量。超过 50%的功能丧失的 ED50 值为 23-38Gy,超过 75%的功能丧失的 ED50 值为 52-68Gy。

结论

平均剂量、aV40 或 aV26 与排泄率和恢复情况有类似的相关性。因此,绝对体积也可用于治疗计划。更长的恢复时间显示出更高的 ED50 值,表明腺体功能部分再生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验